{"id":26395,"date":"2023-04-17T15:44:31","date_gmt":"2023-04-17T15:44:31","guid":{"rendered":"https:\/\/sbpt.org.br\/portal\/?p=26395"},"modified":"2023-04-17T15:44:31","modified_gmt":"2023-04-17T15:44:31","slug":"vacina-high-dose-influenza","status":"publish","type":"post","link":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/","title":{"rendered":"Vacina high-dose para Influenza j\u00e1 est\u00e1 dispon\u00edvel para adultos com 60 anos ou mais"},"content":{"rendered":"<p style=\"text-align: justify\">A partir de 2023, a vacina high-dose para Influenza foi disponibilizada no Brasil para indiv\u00edduos com 60 anos ou mais.<\/p>\n<p style=\"text-align: justify\">A vacina, fabricada pela Sanofi Pasteur com o nome comercial Efluelda\u00ae, <a href=\"https:\/\/consultas.anvisa.gov.br\/#\/medicamentos\/25351890048202005\/?nomeProduto=efluelda\" target=\"_blank\" rel=\"noopener noreferrer\">foi registrada<\/a> pela Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) em maio de 2022.<\/p>\n<p style=\"text-align: justify\">O Dr. Clystenes Soares Silva, Diretor de Ensino da SBPT, esclarece que o imunizante cont\u00e9m quatro vezes mais ant\u00edgenos em compara\u00e7\u00e3o \u00e0s vacinas influenza quadrivalentes de dose padr\u00e3o.<\/p>\n<p><strong><a href=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2023\/04\/V\u00eddeo-vacina-high-dose-20mb.mp4\" target=\"_blank\" rel=\"noopener noreferrer\">Clique aqui para assistir ao v\u00eddeo e baixar<\/a>.<\/strong><\/p>\n<p style=\"text-align: justify\">A hist\u00f3ria da humanidade inclui surtos e pandemias causadas pelo v\u00edrus influenza podendo ser considerada uma quest\u00e3o de sa\u00fade p\u00fablica. Os n\u00fameros que traduzem a ocorr\u00eancia da gripe, segundo a <a href=\"https:\/\/www.who.int\/teams\/health-product-policy-and-standards\/standards-and-specifications\/vaccine-standardization\/influenza\" target=\"_blank\" rel=\"noopener noreferrer\">Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS)<\/a> s\u00e3o impressionantes. Todos os anos 5% a 10% da popula\u00e7\u00e3o mundial \u00e9 infectada pelo v\u00edrus, com\u00a0 notifica\u00e7\u00e3o de cerca de 1 bilh\u00e3o de casos da doen\u00e7a. Entre os acometidos, 3 a 5 milh\u00f5es desenvolvem a forma grave e o n\u00famero de \u00f3bitos oscila entre 250.000 a 650.000 por ano, o que \u00e9 extremamente preocupante. (1)<\/p>\n<p style=\"text-align: justify\">A gripe \u00e9 uma doen\u00e7a que pode causar consequ\u00eancias graves e imprevis\u00edveis. Esse processo \u00e9 ainda mais agravado na popula\u00e7\u00e3o com 60 anos ou mais, uma vez que no envelhecimento, o sistema imune passa por um processo natural de enfraquecimento, chamado\u202fimunossenesc\u00eancia. (2)<\/p>\n<p style=\"text-align: justify\">A vacina contra a gripe com alta concentra\u00e7\u00e3o de ant\u00edgenos (High-dose ou HD) cont\u00e9m quatro vezes mais ant\u00edgenos em compara\u00e7\u00e3o \u00e0s vacinas influenza quadrivalentes de dose padr\u00e3o e est\u00e1 licenciada no Brasil para indiv\u00edduos com 60 anos ou mais. \u00c9 fabricada pela Sanofi Pasteur, com o nome comercial Efluelda\u00ae.<\/p>\n<p style=\"text-align: justify\">A Efluelda\u00ae demonstrou 24,2% de efic\u00e1cia incremental quando comparada a vacina de dose padr\u00e3o. Uma meta-an\u00e1lise que avaliou dados colhidos ao longo de 10 temporadas de gripe, demonstrou que a vacina de alta dose oferece benef\u00edcios de prote\u00e7\u00e3o al\u00e9m da gripe, como redu\u00e7\u00e3o de 27% na hospitaliza\u00e7\u00e3o por pneumonia e de 18% nas interna\u00e7\u00f5es por eventos cardiorrespirat\u00f3rios. (3,4,5)<\/p>\n<p style=\"text-align: justify\">Os efeitos colaterais mais comuns evidenciados durante os estudos cl\u00ednicos foram leves e transit\u00f3rios e inclu\u00edram dor, vermelhid\u00e3o no local da inje\u00e7\u00e3o, cefaleia, mialgia e mal-estar. Em um estudo que comparou a vers\u00e3o de alta concentra\u00e7\u00e3o da vacina quadrivalente com a de alta concentra\u00e7\u00e3o da trivalente, alguns destes efeitos secund\u00e1rios foram ligeiramente mais comuns com quadrivalente, mas a maioria foi breve e cessaram em poucos dias. (6)<\/p>\n<p style=\"text-align: justify\">Portanto a popula\u00e7\u00e3o de pessoas idosas com 60 anos ou mais tem a partir desse ano de 2023 a possibilidade de minimizar o risco de contrair influenza e as repercuss\u00f5es para o paciente e para a sociedade de um modo geral, recebendo a vacina quadrivalente high-dose.<\/p>\n<p><a href=\"https:\/\/consultas.anvisa.gov.br\/#\/bulario\/q\/?numeroRegistro=183260489\" target=\"_blank\" rel=\"noopener noreferrer\">Consulte a bula do produto<\/a>.<\/p>\n<p style=\"text-align: justify\"><strong>Refer\u00eancias Bibliogr\u00e1ficas<\/strong><\/p>\n<ol>\n<li style=\"text-align: justify\">Influenza. World Health Organization, 2018. Dispon\u00edvel em: https:\/\/www.who.int\/teams\/health-product-policy-and-standards\/standards-and-specifications\/vaccine-standardization\/influenza. Acesso em 17 abr 2023.<\/li>\n<li style=\"text-align: justify\">Samson et al. J Diabetes Sci Technol. 2019 Nov 20:1932296819883340.<\/li>\n<li style=\"text-align: justify\">Diazgranados, C. A., et al. (2014). Efficacy of High-Dose versus Standard-Dose influenza vaccine in older adults. N Engl J Med 2014; 371:635-645 DOI: 10.1056\/NEJMoa1315727.<\/li>\n<li style=\"text-align: justify\">Chang LJ, et al. (2019). Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Adults \u226565 Years of Age: A Phase 3 Randomized Clinical Trial. Vaccine. 2019 Sep 16;37(39):5825-5834. doi: 10.1016\/j.vaccine.2019.08.016.<\/li>\n<li style=\"text-align: justify\">U.S. Food and Drug Administration (FDA). (2020). Package Insert \u2013 Fluzone High-Dose Quadrivalent. Sanofi Pasteur. Available at: https:\/\/www.fda.gov\/ media\/132238\/download. [Accessed May 2020].<\/li>\n<li style=\"text-align: justify\">DiazGranados CA et al. Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults. N Engl J Med 2014;371(7):635-645.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"A partir de 2023, a vacina high-dose para Influenza foi disponibilizada no Brasil para indiv\u00edduos com 60 anos ou mais. A vacina, fabricada pela Sanofi Pasteur com o nome comercial Efluelda\u00ae, foi registrada pela Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) em maio de 2022. O Dr. Clystenes Soares Silva, Diretor de Ensino da SBPT, esclarece [\u2026]","protected":false},"author":3,"featured_media":26396,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ngg_post_thumbnail":0,"footnotes":""},"categories":[68],"tags":[1292,1293,1294,313,98,316],"class_list":["post-26395","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","tag-efluelda","tag-gripe","tag-high-dose","tag-influenza","tag-pneumonia","tag-vacina"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vacina high-dose para Influenza j\u00e1 est\u00e1 dispon\u00edvel<\/title>\n<meta name=\"description\" content=\"A partir de 2023, a vacina high-dose para Influenza foi disponibilizada no Brasil para indiv\u00edduos com 60 anos ou mais.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vacina high-dose para Influenza j\u00e1 est\u00e1 dispon\u00edvel\" \/>\n<meta property=\"og:description\" content=\"A partir de 2023, a vacina high-dose para Influenza foi disponibilizada no Brasil para indiv\u00edduos com 60 anos ou mais.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/\" \/>\n<meta property=\"og:site_name\" content=\"sbpt.org.br\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pneumosbpt\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-17T15:44:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2023\/04\/vacina_high_dose_destaques.png\" \/>\n\t<meta property=\"og:image:width\" content=\"350\" \/>\n\t<meta property=\"og:image:height\" content=\"255\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Comunica\u00e7\u00e3o SBPT\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:site\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Comunica\u00e7\u00e3o SBPT\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/vacina-high-dose-influenza\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/vacina-high-dose-influenza\\\/\"},\"author\":{\"name\":\"Comunica\u00e7\u00e3o SBPT\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/adba7f33cf32721354590c6f0eb852d4\"},\"headline\":\"Vacina high-dose para Influenza j\u00e1 est\u00e1 dispon\u00edvel para adultos com 60 anos ou mais\",\"datePublished\":\"2023-04-17T15:44:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/vacina-high-dose-influenza\\\/\"},\"wordCount\":608,\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/vacina-high-dose-influenza\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/vacina_high_dose_destaques.png\",\"keywords\":[\"Efluelda\u00ae\",\"gripe\",\"high-dose\",\"influenza\",\"pneumonia\",\"vacina\"],\"articleSection\":[\"Not\u00edcias\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/vacina-high-dose-influenza\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/vacina-high-dose-influenza\\\/\",\"name\":\"Vacina high-dose para Influenza j\u00e1 est\u00e1 dispon\u00edvel\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/vacina-high-dose-influenza\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/vacina-high-dose-influenza\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/vacina_high_dose_destaques.png\",\"datePublished\":\"2023-04-17T15:44:31+00:00\",\"description\":\"A partir de 2023, a vacina high-dose para Influenza foi disponibilizada no Brasil para indiv\u00edduos com 60 anos ou mais.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/vacina-high-dose-influenza\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/vacina-high-dose-influenza\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/vacina-high-dose-influenza\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/vacina_high_dose_destaques.png\",\"contentUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/vacina_high_dose_destaques.png\",\"width\":350,\"height\":255},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/vacina-high-dose-influenza\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vacina high-dose para Influenza j\u00e1 est\u00e1 dispon\u00edvel para adultos com 60 anos ou mais\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"name\":\"sbpt.org.br\",\"description\":\"Sociedade Brasileira de Pneumologia e Tisiologia\",\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"alternateName\":\"SBPT\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\",\"name\":\"sbpt.org.br\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"contentUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"width\":512,\"height\":512,\"caption\":\"sbpt.org.br\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pneumosbpt\",\"https:\\\/\\\/x.com\\\/pneumosbpt\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/socbraspneumol\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/adba7f33cf32721354590c6f0eb852d4\",\"name\":\"Comunica\u00e7\u00e3o SBPT\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"caption\":\"Comunica\u00e7\u00e3o SBPT\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vacina high-dose para Influenza j\u00e1 est\u00e1 dispon\u00edvel","description":"A partir de 2023, a vacina high-dose para Influenza foi disponibilizada no Brasil para indiv\u00edduos com 60 anos ou mais.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/","og_locale":"pt_BR","og_type":"article","og_title":"Vacina high-dose para Influenza j\u00e1 est\u00e1 dispon\u00edvel","og_description":"A partir de 2023, a vacina high-dose para Influenza foi disponibilizada no Brasil para indiv\u00edduos com 60 anos ou mais.","og_url":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/","og_site_name":"sbpt.org.br","article_publisher":"https:\/\/www.facebook.com\/pneumosbpt","article_published_time":"2023-04-17T15:44:31+00:00","og_image":[{"width":350,"height":255,"url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2023\/04\/vacina_high_dose_destaques.png","type":"image\/png"}],"author":"Comunica\u00e7\u00e3o SBPT","twitter_card":"summary_large_image","twitter_creator":"@pneumosbpt","twitter_site":"@pneumosbpt","twitter_misc":{"Escrito por":"Comunica\u00e7\u00e3o SBPT","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/#article","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/"},"author":{"name":"Comunica\u00e7\u00e3o SBPT","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/adba7f33cf32721354590c6f0eb852d4"},"headline":"Vacina high-dose para Influenza j\u00e1 est\u00e1 dispon\u00edvel para adultos com 60 anos ou mais","datePublished":"2023-04-17T15:44:31+00:00","mainEntityOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/"},"wordCount":608,"publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/#primaryimage"},"thumbnailUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2023\/04\/vacina_high_dose_destaques.png","keywords":["Efluelda\u00ae","gripe","high-dose","influenza","pneumonia","vacina"],"articleSection":["Not\u00edcias"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/","url":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/","name":"Vacina high-dose para Influenza j\u00e1 est\u00e1 dispon\u00edvel","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/#primaryimage"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/#primaryimage"},"thumbnailUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2023\/04\/vacina_high_dose_destaques.png","datePublished":"2023-04-17T15:44:31+00:00","description":"A partir de 2023, a vacina high-dose para Influenza foi disponibilizada no Brasil para indiv\u00edduos com 60 anos ou mais.","breadcrumb":{"@id":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/#primaryimage","url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2023\/04\/vacina_high_dose_destaques.png","contentUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2023\/04\/vacina_high_dose_destaques.png","width":350,"height":255},{"@type":"BreadcrumbList","@id":"https:\/\/sbpt.org.br\/portal\/vacina-high-dose-influenza\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sbpt.org.br\/portal\/"},{"@type":"ListItem","position":2,"name":"Vacina high-dose para Influenza j\u00e1 est\u00e1 dispon\u00edvel para adultos com 60 anos ou mais"}]},{"@type":"WebSite","@id":"https:\/\/sbpt.org.br\/portal\/#website","url":"https:\/\/sbpt.org.br\/portal\/","name":"sbpt.org.br","description":"Sociedade Brasileira de Pneumologia e Tisiologia","publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"alternateName":"SBPT","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sbpt.org.br\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/sbpt.org.br\/portal\/#organization","name":"sbpt.org.br","url":"https:\/\/sbpt.org.br\/portal\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/","url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","contentUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","width":512,"height":512,"caption":"sbpt.org.br"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pneumosbpt","https:\/\/x.com\/pneumosbpt","https:\/\/www.linkedin.com\/company\/pneumosbpt\/","https:\/\/www.instagram.com\/pneumosbpt\/","https:\/\/www.youtube.com\/user\/socbraspneumol"]},{"@type":"Person","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/adba7f33cf32721354590c6f0eb852d4","name":"Comunica\u00e7\u00e3o SBPT","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","caption":"Comunica\u00e7\u00e3o SBPT"}}]}},"_links":{"self":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/26395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/comments?post=26395"}],"version-history":[{"count":0,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/26395\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media\/26396"}],"wp:attachment":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media?parent=26395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/categories?post=26395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/tags?post=26395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}